tiprankstipranks
Trending News
More News >
Shell denies deal talks with BP, Micron reports Q3 beat: Morning Buzz
PremiumThe FlyShell denies deal talks with BP, Micron reports Q3 beat: Morning Buzz
13d ago
New Incyte CEO fuels M&A speculation, says RBC Capital
Premium
The Fly
New Incyte CEO fuels M&A speculation, says RBC Capital
13d ago
Incyte CEO Herve Hoppenot to retire, Bill Meury to succeed
Premium
The Fly
Incyte CEO Herve Hoppenot to retire, Bill Meury to succeed
13d ago
Incyte confirms FDA approval of Monjuvi for refractory follicular lymphoma
PremiumThe FlyIncyte confirms FDA approval of Monjuvi for refractory follicular lymphoma
21d ago
FDA approves Incyte’s tafasitamab-cxix for refractory follicular lymphoma
Premium
The Fly
FDA approves Incyte’s tafasitamab-cxix for refractory follicular lymphoma
21d ago
Positive Buy Rating for Incyte Driven by Promising INCA33989 Trial Results and Favorable Safety Profile
Premium
Ratings
Positive Buy Rating for Incyte Driven by Promising INCA33989 Trial Results and Favorable Safety Profile
22d ago
Promising Phase 1 Results for Incyte’s INCA033989 Support Buy Rating Amid Strategic Developments
PremiumRatingsPromising Phase 1 Results for Incyte’s INCA033989 Support Buy Rating Amid Strategic Developments
23d ago
Incyte’s Promising Developments in ET Treatment and Strategic Partnerships Drive Buy Rating
Premium
Ratings
Incyte’s Promising Developments in ET Treatment and Strategic Partnerships Drive Buy Rating
23d ago
Cautious Optimism for Incyte’s INCA33989 Amid Promising Data and Uncertain Timelines
Premium
Ratings
Cautious Optimism for Incyte’s INCA33989 Amid Promising Data and Uncertain Timelines
23d ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100